Welcome to the NEW CHUG— your ultimate destination for cutting-edge insights and discussions at the intersection of healthcare and technology.

Our platform is dedicated to exploring the dynamic landscape of healthcare technology, empowering professionals, enthusiasts, and innovators alike with the knowledge and resources to navigate the rapidly evolving field.

From telemedicine revolutionizing patient care to the transformative potential of artificial intelligence in diagnostics, we delve into a myriad of topics shaping the future of healthcare delivery. Whether you’re a seasoned healthcare IT professional, an aspiring entrepreneur in the digital health space, or simply curious about the latest innovations, our curated content, expert interviews, and thought-provoking articles provide a comprehensive exploration of healthcare technology’s most pressing issues.

Join us as we navigate the forefront of innovation, driving forward the transformation of healthcare for a healthier, more connected world.

Have questions or suggestions? Please use the contact button below.

NDC Code	:	58160-825-52
Package Description	:	10 SYRINGE in 1 CARTON (58160-825-52) > .5 mL in 1 SYRINGE (58160-825-43)
Product NDC	:	58160-825
Product Type Name	:	VACCINE
Proprietary Name	:	HAVRIX
Non-Proprietary Name	:	Hepatitis A Vaccine
Dosage Form	:	INJECTION, SUSPENSION
Usage	:	INTRAMUSCULAR
Start Marketing Date	:	20070216
Marketing Category Name	:	BLA
Application Number	:	BLA103475
Manufacturer	:	GlaxoSmithKline Biologicals SA
Substance Name	:	HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)
Strength	:	720
Strength Unit	:	[iU]/.5mL
Pharmacy Classes	:	Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

NDC Code

58160-825-52

Package Description

10 SYRINGE in 1 CARTON (58160-825-52) > .5 mL in 1 SYRINGE (58160-825-43)

Product NDC

58160-825

Product Type Name

VACCINE

Proprietary Name

HAVRIX

Non-Proprietary Name

Hepatitis A Vaccine

Dosage Form

INJECTION, SUSPENSION

Usage

INTRAMUSCULAR

Start Marketing Date

20070216

Marketing Category Name

BLA

Application Number

BLA103475

Manufacturer

GlaxoSmithKline Biologicals SA

Substance Name

HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)

Strength

720

Strength Unit

[iU]/.5mL

Pharmacy Classes

Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Welcome to the NEW CHUG— your ultimate destination for cutting-edge insights and discussions at the intersection of healthcare and technology.

Immunization HTML Form - New Vaccines

Structural information on the "58160-825-52" National Drug Code (NDC)